{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T03:27:04Z","timestamp":1784431624987,"version":"3.55.0"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Heilongjiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["PL2025H283"],"award-info":[{"award-number":["PL2025H283"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.gene.2026.150260","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:48:42Z","timestamp":1780616922000},"page":"150260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Roles of m6A erasers FTO and ALKBH5 in drug resistance of hepatocellular carcinoma: mechanisms and clinical implications"],"prefix":"10.1016","volume":"1006","author":[{"given":"Qin","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2026.150260_b0005","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3390\/biom14080932","article-title":"The RNA demethylases ALKBH5 and FTO regulate the translation of ATF4 mRNA in sorafenib-treated hepatocarcinoma cells","volume":"14","author":"Adjibade","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.gene.2026.150260_b0010","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3390\/cells10071715","article-title":"metabolic reprogramming, and drug resistance in liver cancer","volume":"10","author":"Bao","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.gene.2026.150260_b0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41419-021-03505-1","article-title":"The crosstalk between HIFs and mitochondrial dysfunctions in cancer development","volume":"12","author":"Bao","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150260_b0020","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41419-023-05930-w","article-title":"Ferroptosis as a potential target for cancer therapy","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150260_b0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Trans. Targeted Ther."},{"key":"10.1016\/j.gene.2026.150260_b0030","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.7150\/ijbs.107195","article-title":"Regulated cell death in lenvatinib resistance of hepatocellular carcinoma: from molecular mechanisms to therapeutic strategies","volume":"21","author":"Chen","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.gene.2026.150260_b0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduction Targeted Ther."},{"key":"10.1016\/j.gene.2026.150260_b0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gutjnl-2024-331903","article-title":"Targeting the oncogenic m6A demethylase FTO suppresses tumourigenesis and potentiates immune response in hepatocellular carcinoma","volume":"74","author":"Chen","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.gene.2026.150260_b0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12943-020-01239-w","article-title":"ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1","volume":"19","author":"Chen","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150260_b0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13578-024-01225-5","article-title":"Crosstalk between m6A modification and autophagy in cancer","volume":"14","author":"Chen","year":"2024","journal-title":"Cell Biosci."},{"key":"10.1016\/j.gene.2026.150260_b0055","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.7150\/ijbs.120058","article-title":"Unveiling the dynamics and therapeutic potential of m6A methyltransferases and demethylases in liver diseases","volume":"21","author":"Chen","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.gene.2026.150260_b0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/cancers18010039","article-title":"Mechanisms of immune checkpoint inhibitor resistance in hepatocellular carcinoma and strategies for reversal","volume":"18","author":"Dai","year":"2026","journal-title":"Cancers"},{"key":"10.1016\/j.gene.2026.150260_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046571","article-title":"Lactate activates HIF-1 in oxidative but not in warburg-phenotype human tumor cells","volume":"7","author":"De Saedeleer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2026.150260_b0070","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1158\/0008-5472.CAN-21-1456","article-title":"ALKBH5 facilitates hypoxia-induced paraspeckle assembly and IL8 secretion to generate an immunosuppressive tumor microenvironment","volume":"81","author":"Dong","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150260_b0075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ags3.12772","article-title":"Exosomal circ_0032704 confers sorafenib resistance to hepatocellular carcinoma and contributes to cancer malignant progression by modulating the miR-514a-3p\/PD-L1 pathway","volume":"8","author":"Dou","year":"2024","journal-title":"Ann. Gastroenterol. Surg."},{"key":"10.1016\/j.gene.2026.150260_b0080","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.gendis.2023.06.017","article-title":"IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment","volume":"11","author":"Duan","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.gene.2026.150260_b0085","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41419-024-06955-5","article-title":"Autophagy modulation attenuates sorafenib resistance in HCC induced in rats","volume":"15","author":"Elleithi","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150260_b0090","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.gendis.2020.06.011","article-title":"Reversible N6-methyladenosine of RNA: the regulatory mechanisms on gene expression and implications in physiology and pathology","volume":"7","author":"Fang","year":"2020","journal-title":"Genes Dis."},{"key":"10.1016\/j.gene.2026.150260_b0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40164-022-00298-7","article-title":"Role of m6A writers, erasers and readers in cancer","volume":"11","author":"Fang","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.gene.2026.150260_b0100","article-title":"Effects of writers, erasers and readers within miRNA-related m6A modification in cancers","volume":"56","author":"Feng","year":"2022","journal-title":"Cell Prolif."},{"key":"10.1016\/j.gene.2026.150260_b0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.omto.2021.06.017","article-title":"R-2HG downregulates ER\u03b1 to inhibit cholangiocarcinoma via the FTO\/m6A-methylated ER\u03b1\/miR16-5p\/YAP1 signal pathway","volume":"23","author":"Gao","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.gene.2026.150260_b0110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13578-024-01286-6","article-title":"Insights into the m6A demethylases FTO and ALKBH5\u00a0: structural, biological function, and inhibitor developmen","volume":"14","author":"Gao","year":"2024","journal-title":"Cell Biosci."},{"key":"10.1016\/j.gene.2026.150260_b0115","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.3390\/cancers16233944","article-title":"Resistance to tyrosine kinase inhibitors in hepatocellular carcinoma (HCC): clinical implications and potential strategies to overcome the resistance","volume":"16","author":"Gawi Ermi","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.gene.2026.150260_b0120","article-title":"RNA m6A modification in cancers: molecular mechanisms and potential clinical applications","volume":"1","author":"Gu","year":"2020","journal-title":"Innovation"},{"key":"10.1016\/j.gene.2026.150260_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1207496","article-title":"Mechanism of sorafenib resistance associated with ferroptosis in HCC","volume":"14","author":"Guo","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.gene.2026.150260_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116479","article-title":"Demethylases in tumors and the tumor microenvironment: key modifiers of N6-methyladenosine methylation","volume":"174","author":"Guo","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.gene.2026.150260_b0135","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41419-021-03868-5","article-title":"Interactions between m6A modification and miRNAs in malignant tumors","volume":"12","author":"Han","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150260_b0140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41420-024-02092-2","article-title":"Progression of m6A in the tumor microenvironment: hypoxia, immune and metabolic reprogramming","volume":"10","author":"Han","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.gene.2026.150260_b0145","first-page":"1020","article-title":"Exploring circulating tumor cells: detection methods and biomarkers for clinical evaluation in hepatocellular carcinoma","volume":"12","author":"Hsu","year":"2024","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.gene.2026.150260_b0150","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1097\/JS9.0000000000002294","article-title":"Advancements in elucidating the mechanisms of sorafenib resistance in hepatocellular carcinoma","volume":"111","author":"Huang","year":"2025","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.gene.2026.150260_b0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/JHC.S447578","article-title":"Advances in targeted drug resistance associated with dysregulation of lipid metabolism in hepatocellular carcinoma","volume":"11","author":"Huang","year":"2024","journal-title":"J. Hepatocell Carcinoma"},{"key":"10.1016\/j.gene.2026.150260_b0160","doi-asserted-by":"crossref","first-page":"D275","DOI":"10.1093\/nar\/gkae924","article-title":"RMVar 2.0: an updated database of functional variants in RNA modifications","volume":"53","author":"Huang","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2026.150260_b0165","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3390\/ijms24021417","article-title":"Cellular and molecular biology of cancer stem cells of hepatocellular carcinoma","volume":"24","author":"Jeng","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2026.150260_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116375","article-title":"Targeting FTO suppresses hepatocellular carcinoma by inhibiting ERBB3 and TUBB4A expression","volume":"226","author":"Jiang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.gene.2026.150260_b0175","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1186\/s12967-025-07155-1","article-title":"Hypoxia-mediated m6A modulation in hepatocellular carcinoma: a comprehensive review","volume":"23","author":"Jiang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.gene.2026.150260_b0180","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-020-01161-1","article-title":"m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107\/LATS2\u2013mediated YAP activity in NSCLC","volume":"19","author":"Jin","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150260_b0185","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.3390\/ijms252212150","article-title":"The emerging role of IGF2BP2 in cancer therapy resistance: from molecular mechanism to future potential","volume":"25","author":"Li","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2026.150260_b0190","article-title":"Decoding the immunoregulatory functions of ALKBH5 in the tumor microenvironment","volume":"16","author":"Li","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.gene.2026.150260_b0195","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/metabo14060325","article-title":"Crosstalk between epigenetics and metabolic reprogramming in metabolic dysfunction-associated steatotic liver disease-induced hepatocellular carcinoma: a new sight","volume":"14","author":"Li","year":"2024","journal-title":"Metabolites"},{"key":"10.1016\/j.gene.2026.150260_b0200","doi-asserted-by":"crossref","first-page":"20159","DOI":"10.1073\/pnas.1918986117","article-title":"ALKBH5 regulates anti\u2013PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment","volume":"117","author":"Li","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.gene.2026.150260_b0205","first-page":"6084","article-title":"m6A demethylase FTO promotes hepatocellular carcinoma tumorigenesis via mediating PKM2 demethylation","volume":"11","author":"Li","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.gene.2026.150260_b0210","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41419-022-04848-z","article-title":"Mechanism of cancer stemness maintenance in human liver cancer","volume":"13","author":"Liang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150260_b0215","doi-asserted-by":"crossref","first-page":"D194","DOI":"10.1093\/nar\/gkad691","article-title":"m6A-Atlas v2.0: updated resources for unraveling the N6-methyladenosine (m6A) epitranscriptome among multiple species","volume":"52","author":"Liang","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2026.150260_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1696113","article-title":"The impact of metabolic reprogramming in hepatocellular carcinoma on T cell","volume":"16","author":"Liao","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.gene.2026.150260_b0225","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1447135","article-title":"The role of RNA m6A demethylase ALKBH5 in the mechanisms of fibrosis","volume":"12","author":"Liao","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.gene.2026.150260_b0230","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103181","article-title":"RNA m6A methylation regulates sorafenib resistance in liver cancer through FOXO3\u2010mediated autophagy","volume":"39","author":"Lin","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.gene.2026.150260_b0235","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12943-022-01620-x","article-title":"Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance","volume":"21","author":"Lin","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150260_b0240","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cmet.2021.04.001","article-title":"Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance","volume":"33","author":"Liu","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.gene.2026.150260_b0245","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12943-019-1119-7","article-title":"m6A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma","volume":"18","author":"Liu","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150260_b0250","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40164-023-00386-2","article-title":"Emerging roles of m6A RNA modification in cancer therapeutic resistance","volume":"12","author":"Liu","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.gene.2026.150260_b0255","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12943-022-01680-z","article-title":"Biological and pharmacological roles of m6A modifications in cancer drug resistance","volume":"21","author":"Liu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150260_b0260","doi-asserted-by":"crossref","unstructured":"Lu J, O DC-Y, Tsui Y-M, Ng IO-L. Cancer stem cells in hepatocellular carcinoma: platforms, updates, challenges and future perspectives. Cancer Biol Med. 2025. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2025.0622.","DOI":"10.20892\/j.issn.2095-3941.2025.0622"},{"key":"10.1016\/j.gene.2026.150260_b0265","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41598-024-84050-7","article-title":"ALKBH5 acts a tumor-suppressive biomarker and is associated with immunotherapy response in hepatocellular carcinoma","volume":"15","author":"Ma","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150260_b0270","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1158\/1541-7786.MCR-23-0720","article-title":"Hepatitis B virus\u2013mediated m6A demethylation increases hepatocellular carcinoma stemness and immune escape","volume":"22","author":"Meng","year":"2024","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.gene.2026.150260_b0275","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/biom14081042","article-title":"The role of m6A methylation in tumor immunity and immune-associated disorder","volume":"14","author":"Mu","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.gene.2026.150260_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.lddd.2025.100268","article-title":"Emerging DNA- and RNA-based therapeutic strategies in hepatocellular carcinoma: a molecular approach to precision medicine","volume":"22","author":"Nooreen","year":"2025","journal-title":"Lett. Drug Des. Discovery"},{"key":"10.1016\/j.gene.2026.150260_b0285","article-title":"Interactions between ALKBH5 and reader proteins in tumors: functions and molecular mechanisms. Front","volume":"15","author":"Ou","year":"2025","journal-title":"Oncol."},{"key":"10.1016\/j.gene.2026.150260_b0290","article-title":"Applications of single-cell multi-omics in liver cancer","volume":"6","author":"Peeters","year":"2024","journal-title":"JHEP Rep."},{"key":"10.1016\/j.gene.2026.150260_b0295","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3390\/genes14081653","article-title":"Changes in m6A in Steatotic Liver Disease","volume":"14","author":"Petri","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.gene.2026.150260_b0300","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41419-025-08105-x","article-title":"Resistance of first-line targeted drugs in hepatocellular carcinoma: the epigenetic regulation mechanisms","volume":"16","author":"Qi","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150260_b0305","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13045-022-01224-4","article-title":"RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential","volume":"15","author":"Qu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.gene.2026.150260_b0310","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31311","article-title":"YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs","volume":"6","author":"Roundtree","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.gene.2026.150260_b0315","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.apsb.2022.01.003","article-title":"Detailed resume of RNA m6A demethylases","volume":"12","author":"Shen","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.gene.2026.150260_b0320","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3390\/cells10030678","article-title":"Hypoxia-driven effects in cancer: characterization, mechanisms, and therapeutic implications","volume":"10","author":"Shi","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.gene.2026.150260_b0325","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2026.1772310","article-title":"Recent advances in m6A RNA modification in hepatocellular carcinoma: from mechanisms to therapeutic potential","volume":"13","author":"Shi","year":"2026","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.gene.2026.150260_b0330","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkac750","article-title":"RMDisease V2.0: an updated database of genetic variants that affect RNA modifications with disease and trait implication","volume":"51","author":"Song","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2026.150260_b0335","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.gpb.2022.09.001","article-title":"m6A-TSHub: unveiling the context-specific m6A methylation and m6A-affecting mutations in 23 human tissues","volume":"21","author":"Song","year":"2023","journal-title":"Genom. Proteom. Bioinform."},{"key":"10.1016\/j.gene.2026.150260_b0340","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","article-title":"R-2HG exhibits anti-tumor activity by targeting FTO\/m6A\/MYC\/CEBPA signaling","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.gene.2026.150260_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115293","article-title":"\u03b2-HB treatment reverses sorafenib resistance by shifting glycolysis-lactate metabolism in HCC. Biomed Pharmacother =","volume":"166","author":"Suk","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.gene.2026.150260_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114023","article-title":"Role of m6A modification in dysregulation of Wnt\/\u03b2-catenin pathway in cancer","volume":"157","author":"Tabnak","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.gene.2026.150260_b0355","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduction Targeted Ther."},{"key":"10.1016\/j.gene.2026.150260_b0360","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13046-024-03136-2","article-title":"Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects","volume":"43","author":"Tang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.gene.2026.150260_b0365","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41420-022-01286-w","article-title":"ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma","volume":"8","author":"Tang","year":"2022","journal-title":"Cell Death Discovery"},{"key":"10.1016\/j.gene.2026.150260_b0370","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41556-026-01905-z","article-title":"The lncRNA DAMER selectively guides m6A-dependent regulation of ATF4 and asparagine metabolism under nutrient stress in cancer","volume":"28","author":"Tao","year":"2026","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.gene.2026.150260_b0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016210","article-title":"Human AlkB homologue 5 is a nuclear 2-oxoglutarate dependent oxygenase and a direct target of hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1)","volume":"6","author":"Thalhammer","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2026.150260_b0380","article-title":"Single-cell sequencing and its applications in liver cancer. Front","volume":"12","author":"Tian","year":"2022","journal-title":"Oncol."},{"key":"10.1016\/j.gene.2026.150260_b0385","doi-asserted-by":"crossref","first-page":"25284","DOI":"10.1073\/pnas.2007349117","article-title":"Distinct RNA N-demethylation pathways catalyzed by nonheme iron ALKBH5 and FTO enzymes enable regulation of formaldehyde release rates","volume":"117","author":"Toh","year":"2020","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150260_b0390","doi-asserted-by":"crossref","first-page":"16701","DOI":"10.18632\/oncotarget.24673","article-title":"Antiapoptotic BCL2 proteins determine sorafenib\/regorafenib resistance and BH3mimetic efficacy in hepatocellular carcinoma","volume":"9","author":"Tutusaus","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2026.150260_b0395","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1039\/D5BM00363F","article-title":"GalNAc-functionalized metal\u2013organic frameworks for targeted siRNA delivery: enhancing survivin silencing in hepatocellular carcinoma","volume":"13","author":"Wan","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.gene.2026.150260_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100538","article-title":"Dysregulated N6-methyladenosine (m6A) processing in hepatocellular carcinoma","volume":"25","author":"Wang","year":"2021","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.gene.2026.150260_b0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40164-022-00370-2","article-title":"ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner","volume":"12","author":"Wang","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.gene.2026.150260_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218316","article-title":"The deficiency of ALKBH5 promotes lenvatinib resistance and CD8+ T cell exhaustion via accumulation of the cholesterol metabolite 27HC in hepatocellular carcinoma","volume":"643","author":"Wang","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.gene.2026.150260_b0415","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41419-024-07148-w","article-title":"Autophagy: a critical mechanism of N6-methyladenosine modification involved in tumor progression and therapy resistance","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150260_b0420","article-title":"Research progress on m6A demethylase FTO and its role in gynecological tumors","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.gene.2026.150260_b0425","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.21037\/jgo-2025-363","article-title":"YTHDF1 regulates YTHDF2 stability via m6A-dependent mechanisms in hepatocellular carcinoma: insights from in vitro, in vivo, and multi-cohort clinical studies","volume":"16","author":"Wang","year":"2025","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.gene.2026.150260_b0430","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1080\/15548627.2019.1659617","article-title":"m6A mRNA methylation controls autophagy and adipogenesis by targeting Atg5 and Atg7","volume":"16","author":"Wang","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.gene.2026.150260_b0435","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.21037\/jgo-21-378","article-title":"N6-methyladenosine (m6A) regulatory gene divides hepatocellular carcinoma into three subtypes","volume":"12","author":"Wei","year":"2021","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.gene.2026.150260_b0440","article-title":"YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5\/PD\u2010L1\/VEGFA Axis","volume":"11","author":"Wen","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.gene.2026.150260_b0445","doi-asserted-by":"crossref","first-page":"17299","DOI":"10.1074\/jbc.M114.550350","article-title":"Structures of human ALKBH5 demethylase reveal a unique binding mode for specific single-stranded N6-methyladenosine RNA demethylation","volume":"289","author":"Xu","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2026.150260_b0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-023-03197-x","article-title":"RNA m6A methylation regulators in liver cancer","volume":"24","author":"Xu","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.gene.2026.150260_b0455","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70356","article-title":"Hepatitis B virus promotes angiogenesis in hepatocellular carcinoma by increasing m6A modification of VEGFA mRNA via IGF2BP3","volume":"97","author":"Xu","year":"2025","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.gene.2026.150260_b0460","doi-asserted-by":"crossref","first-page":"D273","DOI":"10.1093\/nar\/gkad1070","article-title":"RMBase v3.0: decode the landscape, mechanisms and functions of RNA modifications","volume":"52","author":"Xuan","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2026.150260_b0465","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.gendis.2021.10.004","article-title":"Dynamic m6A-ncRNAs association and their impact on cancer pathogenesis, immune regulation and therapeutic response","volume":"10","author":"Yan","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.gene.2026.150260_b0470","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","article-title":"Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism","volume":"28","author":"Yang","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.gene.2026.150260_b0475","doi-asserted-by":"crossref","first-page":"15499","DOI":"10.1007\/s00432-023-05309-6","article-title":"The ALKBH5\/SOX4 axis promotes liver cancer stem cell properties via activating the SHH signaling pathway","volume":"149","author":"Yang","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.gene.2026.150260_b0480","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41392-023-01316-8","article-title":"O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N6-methyladenosine-dependent manner","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduction Targeted Ther."},{"key":"10.1016\/j.gene.2026.150260_b0485","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gendis.2021.01.005","article-title":"Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: implications in lipid metabolic disorders","volume":"9","author":"Yang","year":"2021","journal-title":"Genes Dis."},{"key":"10.1016\/j.gene.2026.150260_b0490","doi-asserted-by":"crossref","first-page":"10791","DOI":"10.1038\/s41598-021-89931-9","article-title":"The inhibition of ABCB1\/MDR1 or ABCG2\/BCRP enables doxorubicin to eliminate liver cancer stem cells","volume":"11","author":"Yin","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150260_b0495","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12920-022-01207-x","article-title":"Comprehensive characterization of m6A methylation and its impact on prognosis, genome instability, and tumor microenvironment in hepatocellular carcinoma","volume":"15","author":"Yin","year":"2022","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.gene.2026.150260_b0500","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.molcel.2023.05.010","article-title":"RBM33 is a unique m6A RNA-binding protein that regulates ALKBH5 demethylase activity and substrate selectivity","volume":"83","author":"Yu","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.gene.2026.150260_b0505","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12943-023-01841-8","article-title":"m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism","volume":"22","author":"Yue","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150260_b0510","article-title":"Effect of the hypoxia inducible factor on sorafenib resistance of hepatocellular carcinoma. Front","volume":"11","author":"Zeng","year":"2021","journal-title":"Oncol."},{"key":"10.1016\/j.gene.2026.150260_b0515","doi-asserted-by":"crossref","unstructured":"Zhang T-H, Jo S, Zhang M, Wang K, Gao S-J, Huang Y. Understanding YTHDF2-mediated mRNA degradation by m6A-BERT-deg. ArXiv. 2024;:arXiv:2401.08004v1.","DOI":"10.1093\/bib\/bbae170"},{"key":"10.1016\/j.gene.2026.150260_b0520","first-page":"385","article-title":"FTO promotes hepatocellular carcinoma progression by mediating m6A modification of BUB1 and targeting TGF-\u03b2R1 to activate the TGF-\u03b2 signaling pathway","volume":"13","author":"Zhang","year":"2025","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.gene.2026.150260_b0525","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jcmgh.2022.04.014","article-title":"Single-cell transcriptomics of liver cancer: hype or insights?","volume":"14","author":"Zhang","year":"2022","journal-title":"Cell. Mol Gastroenterol. Hepatol."},{"key":"10.1016\/j.gene.2026.150260_b0530","doi-asserted-by":"crossref","first-page":"D106","DOI":"10.1093\/nar\/gkac1061","article-title":"DirectRMDB: a database of post-transcriptional RNA modifications unveiled from direct RNA sequencing technology","volume":"51","author":"Zhang","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2026.150260_b0535","article-title":"Insights into the role of nucleotide methylation in metabolic-associated fatty liver disease","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.gene.2026.150260_b0540","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1016\/j.molcel.2023.06.024","article-title":"A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling","volume":"83","author":"Zhang","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.gene.2026.150260_b0545","doi-asserted-by":"crossref","unstructured":"Zhao L, Cheng J, Zheng Y, Wu J, Fan J, Sun H, et al. Targeting aerobic glycolysis combats tyrosine kinase inhibitor resistance of hepatocellular carcinoma. https:\/\/doi.org\/10.1002\/ijc.70091.","DOI":"10.1002\/ijc.70091"},{"key":"10.1016\/j.gene.2026.150260_b0550","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jare.2024.04.016","article-title":"Abnormal changes in metabolites caused by m6A methylation modification: The leading factors that induce the formation of immunosuppressive tumor microenvironment and their promising potential for clinical application","volume":"70","author":"Zhao","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.gene.2026.150260_b0555","article-title":"Landscape of m6A RNA methylation regulators in liver cancer and its therapeutic implications","volume":"15","author":"Zhao","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.gene.2026.150260_b0560","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12935-025-03923-7","article-title":"Targeting m6A methylation for early diagnosis and precision medicine in hepatocellular carcinoma","volume":"25","author":"Zheng","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.gene.2026.150260_b0565","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2018.11.006","article-title":"YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma","volume":"442","author":"Zhong","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.gene.2026.150260_b0570","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13578-025-01395-w","article-title":"FTO downregulation-mediated m6A modification resulting in enhanced hepatocellular carcinoma invasion","volume":"15","author":"Zhou","year":"2025","journal-title":"Cell Biosci."},{"key":"10.1016\/j.gene.2026.150260_b0575","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12575-025-00281-6","article-title":"Mechanisms of drug resistance in hepatocellular carcinoma","volume":"27","author":"Zou","year":"2025","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.gene.2026.150260_b0580","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13045-019-0839-x","article-title":"M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma","volume":"13","author":"Zuo","year":"2020","journal-title":"J. Hematol. Oncol."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926002702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926002702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:45:28Z","timestamp":1783712728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111926002702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":116,"alternative-id":["S0378111926002702"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2026.150260","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roles of m6A erasers FTO and ALKBH5 in drug resistance of hepatocellular carcinoma: mechanisms and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2026.150260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150260"}}